Stocks and Investing Stocks and Investing
Fri, February 9, 2018
[ 12:00 AM ] - WOPRAI
Amit Mehrotra Maintained (XPO) at Strong Buy with Increased Target to $133 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Allison Landry Maintained (XPO) at Buy with Decreased Target to $104 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Jeff Farmer Maintained (YUM) at Hold with Decreased Target to $82 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
David Amsellem Downgraded (TEVA) to Sell on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Gregg Gilbert Maintained (TEVA) at Hold with Decreased Target to $18 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Ami Fadia Maintained (TEVA) at Sell with Decreased Target to $16 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Jason Gerberry Maintained (TEVA) at Sell with Decreased Target to $16 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Timna Tanners Maintained (TECK) at Strong Buy with Increased Target to $36 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Kristine Liwag Maintained (TDG) at Hold with Increased Target to $290 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Philip Winslow Maintained (TDC) at Sell with Increased Target to $30 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Wamsi Mohan Maintained (TDC) at Strong Buy with Decreased Target to $45 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Keith Bachman Maintained (TDC) at Hold with Increased Target to $42 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Ryan Thompson Maintained (CDE) at Buy with Decreased Target to $9.5 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (VVV) at Hold with Decreased Target to $27 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Faiza Alwy Maintained (SPB) at Strong Buy with Increased Target to $28 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
David Leiker Maintained (SNA) at Buy with Decreased Target to $211 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Tom Abrams Maintained (TRP) at Buy with Decreased Target to $51 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
David Rodgers Maintained (TRNO) at Hold with Decreased Target to $34 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Gerry Sweeney Initiated (TRNS) at Strong Buy and Held Target at $20 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (TRI) at Hold with Decreased Target to $49 on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Phil Gresh Upgraded (SU) to Buy on, Feb 9th, 2018
[ 12:00 AM ] - WOPRAI
Menno Hulshof Upgraded (SU) to Strong Buy on, Feb 9th, 2018
Thu, February 8, 2018
[ 12:00 AM ] - WOPRAI
Matt Sheerin Maintained (TTMI) at Strong Buy with Decreased Target to $18 on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Ryan Gee Maintained (TTWO) at Buy with Increased Target to $128 on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Stephen Ju Maintained (TTWO) at Hold with Increased Target to $128 on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Brian Nowak Maintained (TTWO) at Buy with Decreased Target to $148 on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Kevin Cassidy Maintained (SYNA) at Strong Buy with Decreased Target to $57 on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Tom Roderick Maintained (BLKB) at Strong Buy with Increased Target to $105 on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Carl Byrnes Initiated (VTVT) at Buy on, Feb 8th, 2018
[ 12:00 AM ] - WOPRAI
Douglas Miehm Initiated (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018

Douglas Miehm Initiated (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018


Published on 2024-10-26 02:47:31 - WOPRAI, Douglas Miehm
  Print publication without navigation


Douglas Miehm of RBC Capital, Initiated "Aurinia Pharmaceuticals Inc." (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018.

Douglas has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas

  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $14 on, Monday, October 23rd, 2017
Contributing Sources